Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Covalent LYTAC Enabled by DNA Aptamers for Immune Checkpoint Degradation Therapy
Yuqing Li, Xueliang Liu, Lu Yu, et al.
Journal of the American Chemical Society (2023)
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Enzyme Core Spherical Nucleic Acid That Enables Enhanced Cuproptosis and Antitumor Immune Response through Alleviating Tumor Hypoxia
Yuting Huang, Xueliang Liu, Jiawei Zhu, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 20, pp. 13805-13816
Closed Access | Times Cited: 36
Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches
Natalie Fuchs, Longfei Zhang, Laura Calvo‐Barreiro, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 68-68
Open Access | Times Cited: 10
Reducing PD-L1 Expression by Degraders and Downregulators as a Novel Strategy to Target the PD-1/PD-L1 Pathway
Zhijie Wang, L. Yuan, Xiaotong Liao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6027-6043
Closed Access | Times Cited: 9
Polyvalent Aptamer Nanodrug Conjugates Enable Efficient Tumor Cuproptosis Therapy Through Copper Overload and Glutathione Depletion
Shuang Wang, Xueliang Liu, Dali Wei, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 44, pp. 30033-30045
Closed Access | Times Cited: 9
An epH-driven DNA nanodevice for impeding metastasis in vivo by selectively blocking cell signaling
Kun Yuan, Hong‐Min Meng, Hongzhi Sun, et al.
National Science Review (2025)
Open Access | Times Cited: 1
Targeted Covalent Modification Strategies for Drugging the Undruggable Targets
Tomonori Tamura, Masaharu Kawano, Itaru Hamachi
Chemical Reviews (2025)
Closed Access | Times Cited: 1
Emerging Trends in DNA Nanotechnology-Enabled Cell Surface Engineering
Fan Xiao, Xuechu Shen, Wenqi Tang, et al.
JACS Au (2025) Vol. 5, Iss. 2, pp. 550-570
Open Access | Times Cited: 1
Multivalent RGD Peptide-Mediated Nanochimera for Lysosomal Degradation of PDL1 Protein
Yanfei Song, Linjie Cui, Zhilin Liu, et al.
Nano Letters (2025)
Closed Access | Times Cited: 1
Polyvalent Aptamer-Functionalized NIR-II Quantum Dots for Targeted Theranostics in High PD-L1-Expressing Tumors
Xin Huang, Jiawei Zhu, Chuhuang Dong, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 17, pp. 21571-21581
Closed Access | Times Cited: 7
Intelligent Modular DNA Lysosome-Targeting Chimera Nanodevice for Precision Tumor Therapy
Meirong Cui, Dan Zhang, Xian Zheng, et al.
Journal of the American Chemical Society (2024)
Closed Access | Times Cited: 7
Lysosome Targeting Chimaeras for Glut1-Facilitated Targeted Protein Degradation
Jinyan Luo, Quan Gao, Kui Tan, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 26, pp. 17728-17737
Closed Access | Times Cited: 6
Targeted degradation of VEGF with bispecific aptamer-based LYTACs ameliorates pathological retinal angiogenesis
Ping Zhou, Sai Zhang, Li Lin, et al.
Theranostics (2024) Vol. 14, Iss. 13, pp. 4983-5000
Open Access | Times Cited: 4
Sonodynamic Nano-LYTACs Reverse Tumor Immunosuppressive Microenvironment for Cancer Immunotherapy
Mengke Xu, Yuxuan Hu, Jiayan Wu, et al.
Journal of the American Chemical Society (2024)
Closed Access | Times Cited: 4
DNA Tetrahedron-Driven Multivalent Proteolysis-Targeting Chimeras: Enhancing Protein Degradation Efficiency and Tumor Targeting
Shiqing Li, Tao Zeng, Zhixing Wu, et al.
Journal of the American Chemical Society (2025)
Closed Access
Bifunctional cascaded single-atom nanozymes for enhanced photodynamic immunotherapy through dual-depressing PD-L1 and regulating hypoxia
Jiansen Li, Chen Cao, Xinlu Zhang, et al.
Biomaterials (2025) Vol. 317, pp. 123106-123106
Closed Access
Unleashing the Power of Covalent Drugs for Protein Degradation
Meng‐Jie Fu, Hang Jin, Shao‐Peng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access
Glycoscience in Advancing PD-1/PD-L1-Axis-Targeted Tumor Immunotherapy
Qianqian Sun, Senlian Hong
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1238-1238
Open Access
Systematic evolution of functional oligonucleotides for targeted protein degradation
Huang Su, Yifan Chen, Xuyang Zhao, et al.
Chem (2025), pp. 102408-102408
Closed Access
Polysaccharides from traditional Chinese medicine and their nano-formulated delivery systems for cancer immunotherapy
Linlin Sun, Yuting Liu, Qihui Sun, et al.
Carbohydrate Polymers (2025) Vol. 357, pp. 123416-123416
Closed Access
Profiling Nascent Tumor Extracellular Vesicles via Metabolic Timestamping and Aptamer-Driven Specific Click Chemistry
Qiuyue Wu, Yinyan Zeng, Wencheng Wang, et al.
Journal of the American Chemical Society (2025)
Closed Access
Multivalent DNA lysosome-targeting chimaera for targeted protein degradation and inhibition of c-Met signaling pathways
Xinhuan Chen, Mengmeng Ji, Xue Bai, et al.
Chemical Engineering Journal (2025), pp. 161974-161974
Closed Access
Recent advances in degraders engaging lysosomal pathways and related nanomedicine
Runxin Lu, Xiaofeng Ni, Sha Diao, et al.
European Journal of Medicinal Chemistry (2025), pp. 117701-117701
Closed Access
Targeted degradation of extracellular proteins: state of the art and diversity of degrader designs
Md. Abdullah Al Mamun, Anush Bakunts, Alexander Chernorudskiy
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Immunomodulatory Prodrug Micelles Imitate Mild Heat Effects to Reshape Tumor Microenvironment for Enhanced Cancer Immunotherapy
Thi-Lan-Huong Ngo, Kuan-Lin Wang, Wen‐Yu Pan, et al.
ACS Nano (2024) Vol. 18, Iss. 7, pp. 5632-5646
Open Access | Times Cited: 3
Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates
Yuying Shi, Gang Fan, Ruirong Tan, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 9
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top